Prolife Industries Annual General Meeting
Prolife Industries Limited held its 32nd Annual General Meeting on September 25, 2026. Shareholders approved financial statements, a dividend, director reappointments, and related party transactions.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
Prolife Industries Limited held its 32nd Annual General Meeting on September 25, 2026. Shareholders approved financial statements, a dividend, director reappointments, and related party transactions.
Prolife Industries Limited announced the book closure and record date for its upcoming 32nd Annual General Meeting and dividend. Book closure spans September 19-25, 2026.
Prolife Industries Limited notified shareholders about the dispatch of Annual Report weblinks for the 32nd AGM as per Regulation 36(1)(b) compliance.
Prolife Industries Limited has scheduled its 32nd Annual General Meeting for September 25, 2026. The Annual Report for 2025-26 is available on the company's website.
Prolife Industries recommended a final dividend of Rs. 0.30 per equity share for FY 2025-26. The 32nd Annual General Meeting is scheduled for September 25, 2026.
Prolife Industries Limited has scheduled a board meeting for August 26, 2026, to discuss dividend declaration and other business matters.
Prolife Industries provided a clarification regarding its XBRL submission of financial results. The company revised the filing to include EPS and balancing figure notes.
Prolife Industries Limited filed its annual SDD Compliance Certificate for FY26. The auditor confirmed proper maintenance of the Structured Digital Database with no non-compliances observed.
Prolife Industries Limited appointed M/s Paresh V. Soni & Co. as Internal Auditor for FY 2026-27. The appointment ensures compliance with SEBI and Companies Act regulations.
Prolife Industries Ltd reported revenue from operations of ₹25.8 Cr (-10.4% YoY) and net profit of ₹2.8 Cr (+211.1% YoY) for H2 FY26.
Prolife Industries Limited reported audited financial results for the fiscal year ended March 31, 2026. The Board also approved appointing Paresh V. Soni & Co. as internal auditors.
Prolife Industries Limited scheduled a board meeting for May 29, 2026. The board will consider and approve audited yearly financial results.
Prolife Industries Limited confirmed that it does not meet the criteria for a 'Large Corporate' as per SEBI Circular No. SEBVHO/DDHS/DDHS-RACPOD1/P/CIR/2023/172. Consequently, the company is not required to file an Annual Disclosure in Annexure B for the financial year ended March 31, 2026. This filing is a routine regulatory compliance update.
Prolife Industries Limited confirmed it does not fall under the 'Large Corporate' category as defined by SEBI circulars. Consequently, the company is not required to file the initial disclosure in Annexure A for the financial year 2026-27.
Prolife Industries Limited reported a total revenue of ₹57.55 Crore and a net profit after tax of ₹4.68 Crore for the financial year ended March 31, 2025. The board also appointed M/s Paresh V. Soni & Co. as internal auditor for FY 2025-26 and Mr. Jitendra Leeya as secretarial auditor for FY 2024-25.
Prolife Industries Limited submitted its quarterly compliance certificate under SEBI Regulations for the period ended March 31, 2026. The certificate, issued by MUFG Intime India, confirms the processing and listing of securities received for dematerialisation during the quarter.